According to Kremer-Tal, MigVax is hoping for its oral vaccine to be market-ready within 12-18 months. The company is slated to start human trials for its vaccine by the end of the summer or the beginning of the fall, she added.
Read more here.
According to Kremer-Tal, MigVax is hoping for its oral vaccine to be market-ready within 12-18 months. The company is slated to start human trials for its vaccine by the end of the summer or the beginning of the fall, she added.
Read more here.
![[Hailo in PR Newswire] Lanner Electronics Collaborates with Hailo to unveil revolutionary PCIe AI Acceleration Card – Falcon Lite](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-link.svg)
![[mPrest in Public Utilities Fortnightly] Distributech: Andy Bennett](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
